[ad_1] (Reuters) – A booster shot of an experimental vaccine being developed by SK Bioscience has shown “durable protection” against the Omicron variant in Rhesus macaques, according to new data. The monkeys had received two initial doses of the vaccine plus a booster 6 or 12 months later. Blood samples from the boosted primates showed…
[ad_1] (Reuters) – The AstraZeneca antibody shots given to prevent COVID-19 in high-risk children and adults with weakened immune systems do not adequately protect organ transplant recipients from the Omicron variant, researchers found. The drug, Evusheld, did protect against the Delta variant in kidney transplant recipients, and lab test results released on Monday show Evusheld…
[ad_1] More than 4 in 10 (41%) family physicians report having been involved in a malpractice lawsuit in 2021, down from 40% in 2020. Attorneys who specialize in such lawsuits attributed the decline to the fact that fewer people have received healthcare in person during the COVID-19 pandemic, along with a general sense of gratitude…
[ad_1] (Reuters Health) – Screening women for medication abortion eligibility by patient history alone is effective and safe, suggests a new study that included both in-person dispensing and mailed medication. The analysis of data from nearly 3,800 women in 34 U.S. states, of whom two thirds were screened in person, revealed that 94.8% had a…
[ad_1] Clinicians are not following guidelines that recommend a de-escalation in surveillance for patients with low-risk non–muscle-invasive bladder cancer (NMIBC), a new study concludes. These cancers are associated with low rates of recurrence, progression, and bladder cancer-specific death, and so current clinical practice guidelines recommend against frequent monitoring and testing. However, the study authors…